Stockscreener 앱 받기
6.17
1.91%
-0.12
전일 마감가:
$6.29
열려 있는:
$6.29
하루 거래량:
85,197
Relative Volume:
0.43
시가총액:
$53.06M
수익:
$44.33M
순이익/손실:
$16.05M
주가수익비율:
18.87
EPS:
0.3269
순현금흐름:
$3.85M
1주 성능:
+4.05%
1개월 성능:
-38.30%
6개월 성능:
-77.11%
1년 성능:
-83.96%
1일 변동 폭
$5.82
$6.29
1주일 범위
$5.82
$6.66
52주 변동 폭
$5.77
$46.59
Sanuwave Health Inc Stock (SNWV) Company Profile
명칭
Sanuwave Health Inc
전화
952-656-1029
주소
9600 W. 6TH SSTREET, EDEN PRAIRIE
Compare SNWV vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
1.44 | 2.64B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.65 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.28 | 375.29M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.08 | 281.75M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
48.41 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Northland Capital | Outperform |
| 2025-07-29 | 개시 | Roth Capital | Buy |
Sanuwave Health Inc 주식(SNWV)의 최신 뉴스
SNWV|SNWV|Price:6.170|Chg%:+0.240 - TradingKey
Calendrier des PAPE pour: - Yahoo Finance France
What's going on with SANUWAVE Health stock on Friday? - MSN
Sanuwave Q2 revenue exceeds revised guidance on record consumable sales - scanx.trade
What's Going On With SANUWAVE Health Stock On Friday? - Benzinga
SANUWAVE Health (SNWV) Stock Forum and Discussion - Moomoo
Sanuwave sees Q2 revenue up to $9.8M - MSN
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance - Ortho Spine News
Sanuwave Health preliminary revenue increases up to 5% in Q2 2026 - Medical Buyer
Sanuwave Health (SNWV) Raises Q2 Revenue Expectations to $9.6M-$9.8M - GuruFocus
Sanuwave Health Reports Q2 2026 Revenue Above Guidance Amid Record Consumable Sales and Used System Market Growth - Minichart
Sanuwave Health (SNWV) Reports Second Quarter Revenue Expectatio - GuruFocus
Sanuwave Health, Inc. Revises Earnings Guidance for the Second Quarter Ended June 30, 2026 - marketscreener.com
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance By Investing.com - Investing.com Nigeria
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance - Investing.com
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6-$9.8 Million, Above High End of Revised Guidance - The Manila Times
Sanuwave Health Reports Preliminary Second Quarter 2026 Revenue Above Revised Guidance Range - Quiver Quantitative
Press Release: Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6--$9.8 Million, Above High End of Revised Guidance - Moomoo
A Look at SANUWAVE Health Inc (SNWV) After 3.4% Decline -- GF Va - GuruFocus
SANUWAVE Health (SNWV) director granted 5,524 fully vested stock options - Stock Titan
SANUWAVE Health (SNVW) director granted 5,524 $10 options - Stock Titan
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2000 Dynamic Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000E Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell Small Cap Completeness Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2500 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell 3000 Growth Benchmark - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Sanuwave Health, Inc. Actuals & Estimates (NASDAQ:SNWV) - TradingView
SNWV Q1 2026 Earnings: Wider-Than-Expected Loss Dampens Investor SentimentAnalyst Drop Coverage - DonanımHaber
SNWV Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Stock Rises 4.51%EPS Growth Rate - dars.gov.et
SANUWAVE Health (SNWV) Faces Selling Pressure, Tests Key Support After 4.66% DeclineFactor Rotation - dars.gov.et
SNWV Q1 2026 Earnings: Larger-Than-Expected Loss as Revenue Remains UndisclosedProfit Margin Analysis - dars.gov.et
SNWV: UltraMIST leverages clinical evidence and a consumables model to drive growth amid industry shifts - TradingView
Sanuwave Health eyes revenue up to USD 9.5M in Q2 2026 - Medical Buyer
Sanuwave Health expects Q2 revenue of $8.5M-$9.5M - scanx.trade
Top Midday Decliners - Moomoo
Sanuwave cuts Q2 revenue guidance on weak equipment sales By Investing.com - Investing.com South Africa
Sanuwave Health, Inc. Updates Earnings guidance for the Second Quarter 2026 - marketscreener.com
Sanuwave Health Cuts Q2 Revenue Guidance Amid Market Pressures - TipRanks
Sanuwave cuts Q2 revenue guidance on weak equipment sales - Investing.com
Sanuwave Health Updates Second Quarter 2026 Guidance - The Manila Times
Sanuwave updates Q2 revenue guidance to $8.5–$9.5M, applicator demand strong despite Ultramist headwinds - TradingView
Press Release: Sanuwave Health Updates Second Quarter 2026 Guidance - Moomoo
Sanuwave Health shareholders elect directors and approve auditor at annual meeting - Investing.com
Sanuwave Health Stockholders Approve Directors and Governance Matters - TipRanks
SANUWAVE Health (SNWV) Retreats From Resistance, Testing Key Support LevelsLast Point Support - newsline.com
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Stock RallyRevenue Warning Signal - newsline.com
SANUWAVE Health Q1 2026 Earnings: EPS Misses Estimates; Stock Rises Despite Wider LossROE Trend Analysis - newsline.com
SNWV: Director elections, auditor ratification, and executive pay were voted on; results pending - TradingView
Sanuwave Health Inc (SNWV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sanuwave Health Inc 주식 (SNWV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
May 01 '26 |
Sale |
16.11 |
10,581 |
170,465 |
5,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 28 '26 |
Sale |
18.47 |
46,288 |
854,819 |
7,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 29 '26 |
Sale |
17.25 |
24,360 |
420,152 |
6,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 17 '26 |
Sale |
20.46 |
16,267 |
332,841 |
10,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 21 '26 |
Sale |
20.50 |
202 |
4,142 |
954,798 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 11 '25 |
Sale |
31.28 |
13,500 |
422,277 |
70,499 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 12 '25 |
Sale |
21.04 |
6,500 |
136,789 |
63,999 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 08 '25 |
Sale |
30.75 |
125,400 |
3,856,050 |
881,390 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 09 '25 |
Sale |
30.58 |
8,785 |
268,679 |
872,605 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 10 '25 |
Sale |
30.39 |
8,625 |
262,129 |
863,980 |
1.04%
11.95%
자본화:
|
볼륨(24시간):